DEAD

Serial Number

88391876

Owner

SUPERNUS PHARMACEUTICALS, INC.

Attorney

Mark D. Simpson

Filing Date

Apr 18, 2019

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

GOT MIGRAINE? Trademark

Serial Number: 88391876

GOT MIGRAINE? is a trademark filed by SUPERNUS PHARMACEUTICALS, INC. on April 18, 2019. The trademark is classified under Class 9 (Computers & Electronics), Class 44 (Medical Services). The application is currently no longer active.

Trademark Classes

Class 9 - Computers & Electronics

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

SUPERNUS PHARMACEUTICALS, INC. (49 trademarks)

1550 EAST GUDE DRIVE
ROCKVILLE, MD 20850

Entity Type: 03

Legal Representation

Attorney of Record

Mark D. Simpson

685 trademarks filed View all →

Correspondence Address

Mark D Simpson SAUL EWING ARNSTEIN & LEHR LLP

1500 MARKET STREET

CENTRE SQUARE WEST

38TH FLOOR

PHILADELPHIA

Trademark Details

Filing Date

April 18, 2019

Registration Date

Not Registered

Published for Opposition

October 27, 2020

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Jan 24, 2022 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Jan 24, 2022 ABN6

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 24, 2021 EXRA

SOU EXTENSION 1 GRANTED

Jun 22, 2021 EX1G

SOU EXTENSION 1 FILED

Jun 22, 2021 EXT1

SOU TEAS EXTENSION RECEIVED

Jun 22, 2021 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Dec 22, 2020 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 27, 2020 NPUB

PUBLISHED FOR OPPOSITION

Oct 27, 2020 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 7, 2020 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 17, 2020 CNSA

EXAMINER'S AMENDMENT ENTERED

Aug 25, 2020 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Aug 25, 2020 GNEN

EXAMINERS AMENDMENT E-MAILED

Aug 25, 2020 GNEA

EXAMINERS AMENDMENT -WRITTEN

Aug 25, 2020 CNEA

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 3, 2020 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 3, 2020 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 3, 2020 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 3, 2020 GNRN

NON-FINAL ACTION E-MAILED

Feb 3, 2020 GNRT

NON-FINAL ACTION WRITTEN

Feb 3, 2020 CNRT

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 30, 2019 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 29, 2019 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 29, 2019 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 28, 2019 GNRN

NON-FINAL ACTION E-MAILED

Jun 28, 2019 GNRT

NON-FINAL ACTION WRITTEN

Jun 28, 2019 CNRT

ASSIGNED TO EXAMINER

Jun 27, 2019 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

May 7, 2019 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 5, 2019 NWOS

NEW APPLICATION ENTERED

Apr 22, 2019 NWAP

Related Trademarks

More from this Owner

ONCE-A-DAY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES

ONCE-A-DAY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

More in Same Class

FINCHECK

THE QUICK STRAP

PRINT BUDII

DEGMEG

CINTANA

COLLENDA